“…The authors were able to further refine and implement their culturally competent intervention based on feedback from these community stakeholders. Ali et al described the personal, financial, and structural barriers that either disable or delay individuals in accessing medicines for type 2 diabetes, especially those who visit the Federally Qualified Health Centers [ 8 ]. Based on their study, interventions that target personal barriers, such as poverty, health status, and psychological distress; financial barriers, such as out-of-pocket costs and employment; and structural barriers, such as health center funding programs for medicine access, should be targeted to achieve improved adherence to medicines.…”